CLOSE X

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE298.70-4.45 (-1.47 %)
PREV CLOSE ( ) 303.15
OPEN PRICE ( ) 301.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18341
TODAY'S LOW / HIGH ( )296.85 303.95
52 WK LOW / HIGH ( )258.6 328.6
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1988
Management Info
Jai Hiremath - Chairman Sameer Hiremath - Managing Director
Registered Office

Address 717 / 718,Maker Chambers V,Nariman Point,
Mumbai,
Maharashtra-400021

Phone 022-39267100 / 62770477

Email info@hikal.com

Website www.hikal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Road,Vikhroli West,Mumbai
Listing : BSE, NSE, MCX
NEWS
23Feb Hikal informs about disclosure
Hikal has informed that the Hon’ble High Court of Bombay, vide its order..
06Jan Hikal informs about disclosure
In continuation of its earlier disclosures dated 15th December 2023 and..
29Dec HIKAL informs about disclosure
In continuation of earlier disclosure dated 15th December 2023, HIKAL ha..
31Aug Hikal informs about press release
Hikal has informed that it enclosed the copies of Public Notice publishe..
22May Hikal informs about board meeting
Pursuant to the provisions of Regulations 29 and 33 of the Securities an..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit162.700000000001783.800000000005
Gross Profit 217.4 1053.6
Operating Profit 649.52624.7
Net Sales 4475.720230.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)16688.90
Shareholding Pattern
PROMOTERS 68.85%
NON-INSTITUTION 21.07%
MUTUAL FUNDS/UTI 3.03%
FI/BANKS/INSURANCE 0.12%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

NSE Member Code 14845 BSE Member Code 6287 MCX Member Code 55240 SEBI REGISTRATION NO :
INZ000190232 in NSE, BSE AND MCX
CDSL DP ID 77800 :
IN-DP-CDSL-393-2018
Terms & Conditions Policy Privacy Policy Cancellation & Refunds Policy Grievance Redressal Mechanism Escalation Matrix Investors can refer the following Linksfor e-voting: https://evoting.cdslindia.com/Evoting/EvotingLogin https://www.evotingindia.com/ https://www.evoting.nsdl.com/ List of Active Authorised Persons Filing of complaints on SMART ODR Portal
Advisory for Investors Complaints Data March 2024 Broking Complaints Data March 2024 PMS Complaints Data March 2024 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.gov.in/scores/Welcome.html)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS|KYC |IPO |CLIENT BANK A/C

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.